Another Step Toward Integrated MR/PET as Favored Imaging Modality in Cardiac Sarcoidosis

Thomas H Schindler; Ines Valenta

doi:10.1016/j.jcmg.2021.12.012

Another Step Toward Integrated MR/PET as Favored Imaging Modality in Cardiac Sarcoidosis

JACC Cardiovasc Imaging. 2022 Mar;15(3):457-459. doi: 10.1016/j.jcmg.2021.12.012. Epub 2022 Feb 16.

Authors

Thomas H Schindler¹, Ines Valenta²

Affiliations

¹ Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University in St Louis, St Louis, Missouri, USA. Electronic address: [email protected].
² Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University in St Louis, St Louis, Missouri, USA.

PMID: 35272810
DOI: 10.1016/j.jcmg.2021.12.012

No abstract available

Keywords: (18)F-fluorodeoxyglucose; T1 mapping; T2 mapping; cardiac sarcoidosis; inflammation; magnetic resonance imaging; myocardial extracellular volume; positron emission tomography.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Magnetic Resonance Spectroscopy
Myocarditis*
Positron-Emission Tomography / methods
Predictive Value of Tests
Sarcoidosis* / diagnostic imaging